LEXINGTON, Mass., March 1, 2018 /PRNewswire/ — CSA Medical, Inc. announced the completion of the treatment phase for its ongoing study The Safety and Feasibility Study of RejuvenAir for Treating Chronic Bronchitis Patients (NCT02483637). This prospective, open label, single arm study of…